查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589463

糖尿病注射筆市場：按產品、應用和分銷管道分類 - 全球預測 2025-2030 年

Diabetes Injection Pens Market by Product (Insulin Pens, Pen Needles), Usage (Disposable, Reusable), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年糖尿病注射筆市場價值為165億美元，預計到2024年將達到174.6億美元，複合年成長率為5.87%，到2030年將達到246.1億美元。

糖尿病注射筆市場包括用於注射胰島素和其他糖尿病藥物的設備。這些筆提供準確的劑量、易於使用並提高糖尿病管理所需的依從性。全球範圍內糖尿病盛行率的上升、人口老化以及患者對與傳統注射器相比侵入性較小的給藥方法的偏好推動了對這些注射筆的需求。根據應用，這些筆廣泛被 1 型和 2 型糖尿病患者使用，分為一次性和可重複使用類型。典型的最終使用者包括醫院、診所和家庭護理機構。市場開拓受到多種因素的影響，例如筆技術的進步提高了易用性和準確性，提高了消費者對糖尿病管理的認知，以及擴大新興市場的醫療基礎設施。最近的商機來自技術整合，例如支援藍牙的筆，可以與行動應用程式同步以追蹤劑量模式，為公司創造利潤豐厚的前景。此外，能夠輸送生物藥品的筆的開發代表了技術創新的新途徑。然而，與糖尿病治療相關的高成本、嚴格的監管要求以及對針頭恐懼症和潛在副作用的擔憂是市場成長的挑戰。為了保持競爭力，企業應該專注於開發具有成本效益、易於使用的整合式數位解決方案的設備。投資無針選擇和生技藥品的研究也可以開拓新的收益來源。儘管存在這些挑戰，但隨著企業透過產品多元化和策略聯盟抓住機遇，市場預計將穩定成長。隨著市場的不斷發展，客製化和採用以患者為中心的解決方案將是佔領開拓細分市場和推動業務成長的關鍵。整體而言，市場競爭激烈，快速發展預示著巨大的擴張和創新潛力。

主要市場統計
基準年[2023] 165億美元
預測年份 [2024] 174.6億美元
預測年份 [2030] 246.1億美元
複合年成長率（%） 5.87%

市場動態：快速發展的糖尿病注射筆市場的關鍵市場洞察

供需的動態交互作用正在改變糖尿病注射筆市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球糖尿病患者數量不斷增加
    • 智慧胰島素筆需求
    • 擴大可重複使用的糖尿病注射筆的採用
  • 市場限制因素
    • 使用筆使用某些類型胰島素的限制
  • 市場機會
    • 透過電子商務輕鬆獲得和便利
    • 先進糖尿病注射筆簡介
  • 市場挑戰
    • 使用不當有感染風險

波特五力：駕馭糖尿病注射筆市場的策略工具

波特的五力框架是了解糖尿病注射筆市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解糖尿病注射筆市場的外部影響

外部宏觀環境因素在塑造糖尿病注射筆市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解糖尿病注射筆市場的競爭格局

對糖尿病注射筆市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣糖尿病注射筆市場供應商的績效評估

FPNV 定位矩陣是評估糖尿病注射筆市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了糖尿病注射筆市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對糖尿病注射筆市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球糖尿病的盛行率正在上升
      • 智慧胰島素筆需求
      • 更多採用可重複使用的糖尿病注射筆
    • 抑制因素
      • 透過筆使用某些類型的胰島素時的限制
    • 機會
      • 透過電子商務管道輕鬆獲得且方便
      • 先進糖尿病注射筆簡介
    • 任務
      • 使用不當有感染風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章糖尿病注射筆市場：依產品

  • 胰島素筆
  • 筆針

第7章按應用分列的糖尿病注射筆市場

  • 一次性的
  • 可重複使用的

第8章糖尿病注射筆市場：依通路分類

  • 糖尿病診所
  • 醫院藥房
  • 網上銷售
  • 零售藥房

第9章北美和南美糖尿病注射筆市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區糖尿病注射筆市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲糖尿病注射市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AstraZeneca PLC
  • Becton, Dickinson, and Company
  • Biocon Limited
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Haselmeier GmbH
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • Pfizer Inc.
  • Sanofi SA
  • Ypsomed Holding AG
Product Code: MRR-4348D129FA0E

The Diabetes Injection Pens Market was valued at USD 16.50 billion in 2023, expected to reach USD 17.46 billion in 2024, and is projected to grow at a CAGR of 5.87%, to USD 24.61 billion by 2030.

The market for diabetes injection pens encompasses devices used to administer insulin and other diabetes medications. These pens offer precise dosing, ease of use, and increased compliance, crucial for diabetes management. The necessity for these pens is driven by the rising prevalence of diabetes globally, an aging population, and patient preference for less invasive administration methods compared to traditional syringes. Application-wise, these pens are widely used by individuals with type 1 and type 2 diabetes and are available in disposable and reusable forms. Key end-users include hospitals, clinics, and homecare settings. Market growth is influenced by factors such as advancements in pen technology, which improve ease of use and accuracy, increasing consumer awareness about diabetes management, and expanding healthcare infrastructure in developing regions. Recent opportunities are powered by technological integration, such as Bluetooth-enabled pens that sync with mobile apps to track dosing patterns, providing a lucrative prospect for companies. Additionally, the development of pens capable of delivering biopharmaceuticals presents new avenues for innovation. However, market growth is challenged by high costs associated with diabetes treatment, stringent regulatory requirements, and concerns over needle phobia and potential side effects. Companies should focus on creating cost-effective, user-friendly devices with integrated digital solutions to remain competitive. Investing in research for needle-free options and biologics delivery can also open new revenue streams. Despite these challenges, the market is expected to see steady growth as companies harness opportunities through product diversification and strategic partnerships. As the market continues to evolve, embracing customization and patient-centric solutions will be key in capturing untapped segments and driving business growth. Overall, the market is competitive, with rapid advancements heralding significant potential for expansion and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 16.50 billion
Estimated Year [2024] USD 17.46 billion
Forecast Year [2030] USD 24.61 billion
CAGR (%) 5.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Injection Pens Market

The Diabetes Injection Pens Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetic patients worldwide
    • Demand for intelligent insulin pen
    • Growth in adoption of reusable diabetes injection pen
  • Market Restraints
    • Limitation on using certain types of insulin through a pen
  • Market Opportunities
    • Easy availability and convenience through e-commerce channel
    • Introduction of advanced diabetes injection pens
  • Market Challenges
    • Risk of infection due to improper use

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Injection Pens Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Injection Pens Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Injection Pens Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Injection Pens Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Injection Pens Market

A detailed market share analysis in the Diabetes Injection Pens Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Injection Pens Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Injection Pens Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Injection Pens Market

A strategic analysis of the Diabetes Injection Pens Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Injection Pens Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Becton, Dickinson, and Company, Biocon Limited, Dexcom Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Haselmeier GmbH, Jiangsu Delfu Medical Device Co., Ltd., Medtronic PLC, Merck KGaA, Novartis AG, Novo Nordisk A/S, Owen Mumford Limited, Pfizer Inc., Sanofi S.A., and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Diabetes Injection Pens Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Insulin Pens and Pen Needles.
  • Based on Usage, market is studied across Disposable and Reusable.
  • Based on Distribution Channel, market is studied across Diabetes Clinics, Hospital Pharmacy, Online Sales, and Retail Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetic patients worldwide
      • 5.1.1.2. Demand for intelligent insulin pen
      • 5.1.1.3. Growth in adoption of reusable diabetes injection pen
    • 5.1.2. Restraints
      • 5.1.2.1. Limitation on using certain types of insulin through a pen
    • 5.1.3. Opportunities
      • 5.1.3.1. Easy availability and convenience through e-commerce channel
      • 5.1.3.2. Introduction of advanced diabetes injection pens
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection due to improper use
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetes Injection Pens Market, by Product

  • 6.1. Introduction
  • 6.2. Insulin Pens
  • 6.3. Pen Needles

7. Diabetes Injection Pens Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Diabetes Injection Pens Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Diabetes Clinics
  • 8.3. Hospital Pharmacy
  • 8.4. Online Sales
  • 8.5. Retail Pharmacy

9. Americas Diabetes Injection Pens Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diabetes Injection Pens Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diabetes Injection Pens Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Becton, Dickinson, and Company
  • 3. Biocon Limited
  • 4. Dexcom Inc.
  • 5. Eli Lilly and Company
  • 6. F. Hoffmann-La Roche AG
  • 7. Haselmeier GmbH
  • 8. Jiangsu Delfu Medical Device Co., Ltd.
  • 9. Medtronic PLC
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. Novo Nordisk A/S
  • 13. Owen Mumford Limited
  • 14. Pfizer Inc.
  • 15. Sanofi S.A.
  • 16. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. DIABETES INJECTION PENS MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETES INJECTION PENS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETES INJECTION PENS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETES INJECTION PENS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2023